{"slideshow_credits": null, "snippet": "Legislation that would have accelerated the process in a way that critics said threatened to erode patient safety was formally released, in a scaled-back version with many of the most controversial provisions left out.", "abstract": "House releases scaled-back draft of bill intended to speed up pace at which Food and Drug Administration approves drugs; critics had charged that changes would impact public safety.", "section_name": "Health", "print_page": "16", "document_type": "article", "byline": {"person": [{"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 1, "organization": ""}], "original": "By SABRINA TAVERNISE"}, "web_url": "http://www.nytimes.com/2015/05/01/health/bill-to-speed-approvals-for-drugs-is-cut-back.html", "lead_paragraph": "Legislation that would have accelerated the process in a way that critics said threatened to erode patient safety was formally released, in a scaled-back version with many of the most controversial provisions left out.", "headline": {"main": "Bill to Speed Approvals for Drugs Is Cut Back", "print_headline": "Bill to Speed Approvals for Drugs Is Cut Back"}, "_id": "5542cc2b38f0d83d46e51ef0", "word_count": "663", "multimedia": [], "pub_date": "2015-05-01T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "2"}, {"name": "persons", "value": "Upton, Fred", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "House of Representatives", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}